Dr. Andrew M. King, MD

Claim this profile

Detroit Receiving Hospital

Studies Opioid Use Disorder
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
Detroit Receiving Hospital

Clinical Trials Andrew M. King, MD is currently running

Image of trial facility.

Buprenorphine

for Opioid Use Disorder

This study will (1) recruit, train and provide resources to approximately 30 Emergency Department (ED) sites throughout the U.S. using implementation facilitation strategies to provide ED-initiated buprenorphine (BUP) for patients presenting with opioid use disorder (OUD) who are not receiving medications for opioid use disorder (MOUD). Once implementation is adequately achieved, the sites will (2) conduct a randomized controlled trial (RCT) to compare the effectiveness of sublingual buprenorphine (SL-BUP) versus extended-release buprenorphine (XR-BUP) on ED patients' engagement in formal addiction treatment 7-days after their ED visit. In addition, in an ancillary component of the study, the investigators will (3) assess the use of XR-BUP in ED patients with Clinical Opioid Withdrawal Scale (COWS) scores \< 8 in a case series to potentially expand the eligibility of patients in the larger RCT to those presenting with little to no opioid withdrawal symptoms. Finally, the investigators will (4) develop and validate ED electronic health record (EHR) opioid-related phenotypes, both of which will inform the main RCT.
Recruiting3 awards Phase 218 criteria

More about Andrew M. King, MD

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Andrew M. King, MD has experience with
  • Buprenorphine Sublingual Product
  • CAM2038
Breakdown of trials Andrew M. King, MD has run
Opioid Use Disorder

Other Doctors you might be interested in

Anthony Lagina, MDDetroit Receiving Hospital
Wazim Mohamed, MDWayne State University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew M. King, MD specialize in?
Andrew M. King, MD focuses on Opioid Use Disorder and other conditions. In particular, much of their work with Opioid Use Disorder has involved treating patients, or patients who are undergoing treatment.
Is Andrew M. King, MD currently recruiting for clinical trials?
Yes, Andrew M. King, MD is currently recruiting for 1 clinical trial in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Andrew M. King, MD has studied deeply?
Yes, Andrew M. King, MD has studied treatments such as Buprenorphine Sublingual Product, CAM2038.
What is the best way to schedule an appointment with Andrew M. King, MD?
Apply for one of the trials that Andrew M. King, MD is conducting.
What is the office address of Andrew M. King, MD?
The office of Andrew M. King, MD is located at: Detroit Receiving Hospital, Detroit, Michigan 48201 United States. This is the address for their practice at the Detroit Receiving Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top